Cargando…

The “Intermediate” CD14 + CD16 + monocyte subpopulation plays a role in IVIG responsiveness of children with Kawasaki disease

BACKGROUND: Kawasaki disease (KD) is an acute, self-limited febrile illness of unknown cause. Intravenous immunoglobulin (IVIG)-resistance are related to greater risk for permanent cardiac complications. We aimed to determine the correlation between monocytes and the phenotype of KD in relation to I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yi Seul, Yang, Hyun Jin, Kee, Seung-Jung, Choi, Insu, Ha, Kisoo, Ki, Katrina K, Jeong, In Seok, Cho, Hwa Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165978/ https://www.ncbi.nlm.nih.gov/pubmed/34059085 http://dx.doi.org/10.1186/s12969-021-00573-7

Ejemplares similares

CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation
por: Sekerkova, Alena, et al.
Publicado: (2014)

The Expression of CD14(+)CD16(+) Monocyte Subpopulation in Coronary Heart Disease Patients with Blood Stasis Syndrome
por: Huang, Ye, et al.
Publicado: (2013)

The “Intermediate” CD14(++)CD16(+) monocyte subset increases in severe peripheral artery disease in humans
por: Wildgruber, Moritz, et al.
Publicado: (2016)

CTRP3 induces an intermediate switch of CD14(++)CD16(+) monocyte subset with anti-inflammatory phenotype
por: Zhu, Hongtao, et al.
Publicado: (2020)

Elevated circulating CD14(++)CD16(+) intermediate monocytes are independently associated with extracardiac complications after cardiac surgery
por: Mossanen, Jana C., et al.
Publicado: (2020)

Changes in the Monocytic Subsets CD14(dim)CD16(+) and CD14(++)CD16(−) in Chronic Systolic Heart Failure Patients
por: Amir, Offer, et al.
Publicado: (2012)

Circulating CD14(bright)CD16(+) ‘Intermediate’ Monocytes Exhibit Enhanced Parasite Pattern Recognition in Human Helminth Infection
por: Turner, Joseph D., et al.
Publicado: (2014)

CD14(bright)CD16+ intermediate monocytes are induced by interleukin-10 and positively correlate with disease activity in rheumatoid arthritis
por: Tsukamoto, Masako, et al.
Publicado: (2017)

Activated Platelets Convert CD14(+)CD16(-) Into CD14(+)CD16(+) Monocytes With Enhanced FcγR-Mediated Phagocytosis and Skewed M2 Polarization
por: Lee, Su Jeong, et al.
Publicado: (2021)

The CD14(+/low)CD16(+) monocyte subset is more susceptible to spontaneous and oxidant-induced apoptosis than the CD14(+)CD16(−) subset
por: Zhao, C, et al.
Publicado: (2010)

CD14CD16 Monocyte Subset Levels in Heart Failure Patients
por: Barisione, Chiara, et al.
Publicado: (2010)

Characterization of the CD14(++)CD16(+) Monocyte Population in Human Bone Marrow
por: Mandl, Manuela, et al.
Publicado: (2014)

Distinct gene expression patterns for CD14++ and CD16++ monocytes in preeclampsia
por: Vishnyakova, Polina, et al.
Publicado: (2022)

Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease
por: Wang, Zhouping, et al.
Publicado: (2020)

Correlation between the Level of Inflammatory Cytokines and Prognosis in Children with IVIG-sensitive Kawasaki Disease and IVIG-resistant Kawasaki Disease
por: Zhang, Hao, et al.
Publicado: (2022)

ADAM17-Mediated Reduction in CD14(++)CD16(+) Monocytes ex vivo and Reduction in Intermediate Monocytes With Immune Paresis in Acute Pancreatitis and Acute Alcoholic Hepatitis
por: Waller, Kathryn, et al.
Publicado: (2019)

Longitudinal immune cell monitoring identified CD14(++) CD16(+) intermediate monocyte as a marker of relapse in patients with ANCA-associated vasculitis
por: Matsumoto, Kotaro, et al.
Publicado: (2020)

Circulating CD14(high) CD16(low) intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression
por: Prat, Mélissa, et al.
Publicado: (2020)

Increased Interleukin-35 suppresses peripheral CD14(+) monocytes function in patients with Kawasaki disease
por: Xing, Haijian, et al.
Publicado: (2020)

The Association of Circulating CD14++CD16+ Monocytes, Natural Killer Cells and Regulatory T Cells Subpopulations With Phenotypes of Cardiovascular Disease in a Cohort of Peritoneal Dialysis Patients
por: Duni, Anila, et al.
Publicado: (2021)

Infiltrating CD16(+) Are Associated with a Reduction in Peripheral CD14(+)CD16(++) Monocytes and Severe Forms of Lupus Nephritis
por: Barrera García, Anabel, et al.
Publicado: (2016)

Elevated Numbers of Circulating Very Small Embryonic-Like Stem Cells (VSELs) and Intermediate CD14++CD16+ Monocytes in IgA Nephropathy
por: Eljaszewicz, Andrzej, et al.
Publicado: (2018)

Intermediate CD14(++)CD16(+) monocytes decline after transcatheter aortic valve replacement and correlate with functional capacity and left ventricular systolic function
por: Neuser, Jonas, et al.
Publicado: (2017)

Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease
por: Han, Chun-Ling, et al.
Publicado: (2018)

Glycolysis Is Required for LPS-Induced Activation and Adhesion of Human CD14(+)CD16(−) Monocytes
por: Lee, Man K. S., et al.
Publicado: (2019)

Author Correction: Distinct gene expression patterns for CD14++ and CD16++ monocytes in preeclampsia
por: Vishnyakova, Polina, et al.
Publicado: (2022)

CD14+ monocytes and soluble CD14 of synovial fluid are associated with osteoarthritis progression
por: Lee, Ha-Reum, et al.
Publicado: (2022)

CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders
por: Williams, Dionna W., et al.
Publicado: (2014)

Therapeutic Window of Intravenous Immunoglobulin (IVIG) and its correlation with IVIG-resistant in Kawasaki Disease: a retrospective study
por: Cai, Jiang Hui, et al.
Publicado: (2022)

Proinflammatory CD14(+)CD16(+) monocytes are associated with vascular stiffness in predialysis patients with chronic kidney disease
por: Lee, Jae-Won, et al.
Publicado: (2013)

Dopamine Increases CD14(+)CD16(+) Monocyte Migration and Adhesion in the Context of Substance Abuse and HIV Neuropathogenesis
por: Coley, Jacqueline S., et al.
Publicado: (2015)

Proinflammatory (CD14+CD16++) monocytes in type 2 diabetes mellitus patients with/without chronic periodontitis
por: Jagannathan, Raghunathan, et al.
Publicado: (2019)

CD14(high)CD16(+) monocytes are the main producers of Interleukin-10 following clinical heart transplantation
por: Ludwig, Kristina, et al.
Publicado: (2023)

CD14(hi)CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so
por: Zhou, Jingling, et al.
Publicado: (2015)

Increases in inflammatory and CD14(dim)/CD16(pos)/CD45(pos) patrolling monocytes in sepsis: correlation with final outcome
por: Gainaru, Gabriela, et al.
Publicado: (2018)

Erratum to: CD14 hi CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so
por: Zhou, Jingling, et al.
Publicado: (2015)

Transient Migration of Large Numbers of CD14(++) CD16(+) Monocytes to the Draining Lymph Node after Onset of Inflammation
por: Lund, Hege, et al.
Publicado: (2016)

A Novel, Five-Marker Alternative to CD16–CD14 Gating to Identify the Three Human Monocyte Subsets
por: Ong, Siew-Min, et al.
Publicado: (2019)

CD14(+)CD16(−) monocytes are the main precursors of osteoclasts in rheumatoid arthritis via expressing Tyro3TK
por: Xue, Jimeng, et al.
Publicado: (2020)

Decrease in CD14++CD16+ Monocytes in Low-Immunological-Risk Kidney Transplant Patients with Subclinical Borderline Inflammation
por: Caballero, Abelardo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4irgojh3cf154dqcrec8sj4hfm